Concepedia

Peter Ellinghaus

PE

45

Publications

3.3K

Citations

31

H-Index

1996

Active since

Affiliations

Bayer (Germany)(Current)

University of Münster

Bayer (United States)

Centre Oscar Lambret

University of Ulsan

Peter Ellinghaus is an author at Bayer (Germany) specializing in medicine, pharmacology, and cancer research.

Top concepts

Publications per year

1996–2022

45

Publications

45

Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function

U. Seedorf, M. Raabe, Peter Ellinghaus et al. · Genes & Development · 1998 · 261 citations · Full text

<scp>BAY</scp> 87‐2243, a highly potent and selective inhibitor of hypoxia‐induced gene activation has antitumor activities by inhibition of mitochondrial complex I

Peter Ellinghaus, Iring Heisler, Kerstin Unterschemmann et al. · Cancer Medicine · 2013 · 221 citations · Full text

, , +21

Phytanic Acid Activates the Peroxisome Proliferator-activated Receptor α (PPARα) in Sterol Carrier Protein 2-/ Sterol Carrier Protein x-deficient Mice

Peter Ellinghaus, Christian Wolfrum, Gerd Assmann et al. · Journal of Biological Chemistry · 1999 · 171 citations · Full text

, , +18

Mimicking Hypoxia to Treat Anemia: HIF-Stabilizer BAY 85-3934 (Molidustat) Stimulates Erythropoietin Production without Hypertensive Effects

Ingo Flamme, Felix Oehme, Peter Ellinghaus et al. · PLoS ONE · 2014 · 168 citations · Full text

Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors

Felix Oehme, Peter Ellinghaus, Peter Kolkhof et al. · Biochemical and Biophysical Research Communications · 2002 · 163 citations

, , +9

Rows per page

1–5 of 45